|
Generic Name : Cisatracurium Besylate
Therapeutic Classification : Neuromuscular Blocking Agents
Trade Name(s): International- Nimbex. Why it is prescribed (Indications) : This medication is a neuromuscular blocking agent, used as an adjunct to general anesthesia. It provides muscle relaxation during surgery. When it is not to be taken (Contraindications): Contraindicated to use in premature infants and patients with known hypersensitivity.
Dosage & When it is to be taken : Adults- IV- 0.2 mg/kg compared to 0.15 mg/kg. Maintenance: 0.03 mg/kg. Children- Initial- The recommended dose for children 2 to 12 years of age is 0.10-0.15 mg/kg. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein. Warnings and Precautions : * It should be administered by a well-trained healthcare provider. * Caution should be exercised in patients with myasthenia gravis, or any neuromuscular disease, who have had previous difficulties with anesthetics, who are taking other medications, any allergy, during pregnancy and breastfeeding. Side Effects : Flushing of the face and upper body, skin rashes, slow heart rate, low blood pressure, difficulty breathing. * Avoid excess dosage. Storage Conditions : Store it in refrigerator (2° to 8°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||



Ask an Expert